Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Historical Holders from Q2 2015 to Q3 2025

Symbol
EVH on NYSE
CUSIP
30050B101
Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
117M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
126M
Holdings value
$1.42B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
216
Number of buys
117
Number of sells
-108
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CADIAN CAPITAL MANAGEMENT, LP 9.3% $108M 10.8M Cadian Capital Management, LP Mar 31, 2025
Durable Capital Partners LP 7.8% $84.5M 9.12M Durable Capital Partners LP Jun 27, 2025
MORGAN STANLEY 7% $76.1M 8.21M Morgan Stanley Jun 30, 2025
FMR LLC 5.6% $61.4M 6.62M FMR LLC Jun 30, 2025
EVENTIDE ASSET MANAGEMENT, LLC 3.5% -34% $36.8M -$17.9M 4.09M -32.8% Eventide Asset Management, LLC Jun 30, 2025
RA CAPITAL MANAGEMENT, L.P. 3.1% $35.9M 3.58M RA Capital Management, L.P. Dec 31, 2024
WELLINGTON MANAGEMENT GROUP LLP 0.4% -95.6% $4.1M -$92.6M 443K -95.8% Wellington Management Group LLP Jun 30, 2025

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 652K $5.52M +$723K $8.46 6
2025 Q2 126M $1.42B +$20.5M $11.26 216
2025 Q1 125M $1.18B +$13.9M $9.47 219
2024 Q4 122M $1.38B -$233M $11.25 237
2024 Q3 128M $3.62B +$9.64M $28.28 260
2024 Q2 130M $2.48B +$67.5M $19.12 239
2024 Q1 124M $4.08B -$50.7M $32.79 249
2023 Q4 510K $16.8M +$99.2K $33.03 1
2023 Q3 121M $3.32B +$134M $27.23 198
2023 Q2 116M $3.51B +$131M $30.30 212
2023 Q1 112M $3.61B +$350M $32.45 236
2022 Q4 95.5M $2.68B +$173M $28.08 226
2022 Q3 92.9M $3.34B +$174M $35.93 237
2022 Q2 85.2M $2.62B +$66.1M $30.71 203
2022 Q1 86.5M $2.79B +$65.9M $32.30 205
2021 Q4 84.7M $2.34B -$21M $27.67 196
2021 Q3 85.5M $2.65B +$85.2M $31.00 204
2021 Q2 83M $1.75B +$24.6M $21.12 173
2021 Q1 81.9M $1.66B +$54.6M $20.20 163
2020 Q4 81.5M $1.31B +$30.6M $16.03 149
2020 Q3 76.2M $950M +$91.6M $12.41 145
2020 Q2 66.7M $474M -$7.6M $7.12 122
2020 Q1 61.8M $334M -$44.2M $5.43 138
2019 Q4 84.4M $764M +$19.6M $9.05 160
2019 Q3 79.4M $571M +$43.3M $7.19 160
2019 Q2 77.2M $613M -$47.9M $7.95 169
2019 Q1 77.8M $979M -$115M $12.58 177
2018 Q4 83.7M $1.67B -$7.99M $19.95 176
2018 Q3 83.5M $2.37B +$83.2M $28.40 183
2018 Q2 79.7M $1.68B +$37.6M $21.05 172
2018 Q1 79.2M $1.13B +$50.8M $14.25 144
2017 Q4 76.7M $944M -$27.9M $12.30 147
2017 Q3 73.3M $1.31B +$165M $17.80 159
2017 Q2 61.9M $1.57B +$502M $25.35 160
2017 Q1 41.6M $919M +$287M $22.30 131
2016 Q4 29.4M $435M +$4.09M $14.80 116
2016 Q3 27.3M $667M +$200M $24.62 107
2016 Q2 18M $345M +$34.8M $19.20 77
2016 Q1 16.5M $174M +$3.04M $10.56 69
2015 Q4 16.1M $195M +$1.69M $12.11 67
2015 Q3 15.8M $252M +$10.1M $15.96 69
2015 Q2 14.8M $287M +$287M $19.50 62